SCHEMBL1695751

SCHEMBL1695751

CCC(=O)OC1CCCCCCC1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 2/20 0.61
EPHX1 P07099 2/20 0.57
HTT P42858 3/20 0.55
CYP2C19 P33261 1/20 0.53
CYP19A1 P11511 2/20 0.47
CHRM2 P08172 2/20 0.43
CHRM4 P08173 2/20 0.43
CHRM1 P11229 2/20 0.43
CHRM3 P20309 2/20 0.43
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
KDM4E B2RXH2 1/20 0.39
EPHX2 P34913 1/20 0.39
NPSR1 Q6W5P4 1/20 0.38
ALDH1A1 P00352 1/20 0.38
ALOX15 P16050 1/20 0.38
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL183236 1.00 NAAA (0.61) NAAAEPHX1HTTCYP2C19CYP19A1
SCHEMBL1595662 1.00 NAAA (0.61) NAAAEPHX1HTTCYP2C19CYP19A1
Hydrochloric Acid SCHEMBL22466282 0.98 NAAA (0.59) NAAAEPHX1HTTCYP2C19CYP19A1
SCHEMBL9577043 0.98 NAAA (0.59) NAAAEPHX1HTTCYP2C19CYP19A1
SCHEMBL7905393 0.98 NAAA (0.59) NAAAEPHX1HTTCYP2C19CYP19A1
SCHEMBL97374 0.98 NAAA (0.60) NAAAEPHX1HTTCYP2C19CYP19A1
Hydrochloric Acid SCHEMBL29626573 0.95 NAAA (0.58) NAAAEPHX1HTTCYP2C19CYP19A1
Benzene SCHEMBL10901065 0.94 NAAA (0.56) NAAAEPHX1HTTCYP2C19CYP19A1
SCHEMBL3631877 0.93
Hydrochloric Acid SCHEMBL32661951 0.91 NAAA (0.53) NAAAEPHX1HTTCYP2C19CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12024579-B2 Curable liquid composition, particulate filler, and compound TOKYO OHKA KOGYO CO., LTD. (JP) 2024-07-02 US disclosed
US-11542397-B2 Liquid composition, quantum dot-containing film, optical film, light-emitting display element panel, and light-emitting display device TOKYO OHKA KOGYO CO., LTD. (JP) 2023-01-03 US disclosed
US-11413682-B2 Method for producing surface-modified metal oxide fine particle, method for producing improved metal oxide fine particles, surface-modified metal oxide fine particles, and metal oxide fine particle dispersion liquid TOKYO OHKA KOGYO CO., LTD. (JP) 2022-08-16 US disclosed
US-20220195097-A1 CURABLE LIQUID COMPOSITION, PARTICULATE FILLER, AND COMPOUND TOKYO OHKA KOGYO CO., LTD. (JP) 2022-06-23 US disclosed
CN-107880545-B Resin composition, method for producing cured product, and cured product 东京应化工业株式会社 2022-03-18 CN disclosed
US-20220073817-A1 METHOD FOR PRODUCING QUANTUM DOT-CONTAINING FILM AND COMPOSITION FOR PRODUCING QUANTUM DOT-CONTAINING FILM TOKYO OHKA KOGYO CO., LTD. (JP) 2022-03-10 US disclosed
US-20220073815-A1 METHOD FOR PRODUCING QUANTUM DOT DISPERSION AND QUANTUM DOT DISPERSION TOKYO OHKA KOGYO CO., LTD. (JP) 2022-03-10 US disclosed
US-20210309866-A1 LIQUID COMPOSITION, QUANTUM DOT-CONTAINING FILM, OPTICAL FILM, LIGHT-EMITTING DISPLAY ELEMENT PANEL, AND LIGHT-EMITTING DISPLAY DEVICE TOKYO OHKA KOGYO CO., LTD. (JP) 2021-10-07 US disclosed
EP-3812805-A1 LIQUID COMPOSITION, QUANTUM DOT-CONTAINING FILM, OPTICAL FILM, LUMINESCENT DISPLAY ELEMENT PANEL, AND LUMINESCENT DISPLAY DEVICE TOKYO OHKA KOGYO CO., LTD. (JP) 2021-04-28 EP disclosed
WO-2021044879-A1 CURABLE COMPOSITION, FILM, OPTICAL FILM FOR LUMINESCENT DISPLAY ELEMENT, LUMINESCENT DISPLAY ELEMENT PANEL, AND LUMINESCENT DISPLAY DEVICE 学校法人慶應義塾 2021-03-11 WO disclosed
US-20130090492-A1 TRANSESTERIFICATION PROCESS USING MIXED SALT ACETYLACETONATES CATALYSTS ECOSYNTH BVBA (BE) 2013-04-11 US disclosed
CN-102977230-A Method for removing hydrogenation catalyst in polymer solution CHINA PETROLEUM & CHEMICAL 2013-03-20 CN disclosed
CN-101333264-B Method for removing residual hydrogenation catalyst after hydrogenation for nonsaturated polymers CHINA PETROLEUM & CHEMICAL 2012-06-27 CN disclosed
WO-2011157645-A2 TRANSESTERIFICATION PROCESS USING MIXED SALT ACETYLACETONATES CATALYSTS ECOSYNTH BVBA (BE) 2011-12-22 WO disclosed
CN-101333264-A Method for removing residual hydrogenation catalyst after hydrogenation for nonsaturated polymers CHINA PETROCHEMICAL CO LTD (CN) 2008-12-31 CN disclosed
US-6337305-B1 HERBICIDES FOR AGRICULTURE BASF AKTIENGESELLSCHAFT (DE) 2002-01-08 US disclosed
EP-0968188-A1 SUBSTITUTED 2-BENZ(O)YLPYRIDINES, THEIR PREPARATION AND THEIR USE AS HERBICIDES BASF AKTIENGESELLSCHAFT (DE) 2000-01-05 EP disclosed
WO-1998042671-A1 SUBSTITUTED 2-BENZ(O)YLPYRIDINES, THEIR PREPARATION AND THEIR USE AS HERBICIDES BASF AKTIENGESELLSCHAFT (DE) 1998-10-01 WO disclosed
US-4112235-A Transesterification of carboxylic acids UOP INC. (US) 1978-09-05 US disclosed
US-4088820-A Transesterification of olefins UOP INC. (US) 1978-05-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130090492-A1 TRANSESTERIFICATION PROCESS USING MIXED SALT ACETYLACETONATES CATALYSTS ACACA, ACACB, ACSL6 NAAA 212/4885EPHX1 3576/4885HTT 3529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.